Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk

ClinicalTrials.gov ID: NCT03315143

Public ClinicalTrials.gov record NCT03315143. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 12:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes, Cardiovascular Risk Factors and Moderately Impaired Renal Function

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of the study was to compare the effect of sotagliflozin to placebo on total occurrences of cardiovascular (CV) death, hospitalization for heart failure \[HHF\], and urgent visit for heart failure \[HF\] in participants with type 2 diabetes, cardiovascular risk factors, and moderate to severely impaired renal function.

Study identification

NCT ID
NCT03315143
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Lexicon Pharmaceuticals
Industry
Enrollment
10,584 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 19, 2017 (Actual)
Primary completion
Jul 8, 2020 (Actual)
Completion
Jul 8, 2020 (Actual)
Last update posted
Oct 28, 2022

2017 – 2020

United States locations

U.S. sites
119
U.S. states
32
U.S. cities
100
Facility City State ZIP Site status
Investigational Site Number 8400017 Birmingham Alabama 35205 —
Investigational Site Number 8400096 Sheffield Alabama 35660 —
Investigational Site Number 8400004 Mesa Arizona 85206 —
Investigational Site Number 8400059 Mesa Arizona 85210 —
Investigational Site Number 8400021 Peoria Arizona 85381 —
Investigational Site Number 8400014 Surprise Arizona 85374 —
Investigational Site Number 8400071 Little Rock Arkansas 72211 —
Investigational Site Number 8400039 Beverly Hills California 90211 —
Investigational Site Number 8400042 Concord California 94520 —
Investigational Site Number 8400089 Fresno California 93720 —
Investigational Site Number 8400006 Huntington Park California 90255 —
Investigational Site Number 8400036 Long Beach California 90807 —
Investigational Site Number 8400073 Los Angeles California 90017 —
Investigational Site Number 8400084 Los Angeles California 90022-4302 —
Investigational Site Number 8400035 Los Gatos California 95032 —
Investigational Site Number 8400043 Northridge California 91325 —
Investigational Site Number 8400025 Sacramento California 95821 —
Investigational Site Number 8400018 San Dimas California 91713 —
Investigational Site Number 8400070 Temecula California 92591 —
Investigational Site Number 8400013 Waterbury Connecticut 06708 —
Investigational Site Number 8400095 Bradenton Florida 34209 —
Investigational Site Number 8400090 Clearwater Florida 33756 —
Investigational Site Number 8400121 Clearwater Florida 33756 —
Investigational Site Number 8400049 Cooper City Florida 33024 —
Investigational Site Number 8400092 Hialeah Florida 33012 —
Investigational Site Number 8400026 Hollywood Florida 33024 —
Investigational Site Number 8400134 Jacksonville Florida 32204 —
Investigational Site Number 8400055 Jacksonville Florida 32207-4966 —
Investigational Site Number 8400056 Jacksonville Florida 32216 —
Investigational Site Number 8400031 Jacksonville Florida 32277 —
Investigational Site Number 8400037 Maitland Florida 32751 —
Investigational Site Number 8400078 Miami Florida 33126 —
Investigational Site Number 8400117 Miami Florida 33135 —
Investigational Site Number 8400119 Miami Florida 33135 —
Investigational Site Number 8400118 Miami Florida 33165 —
Investigational Site Number 8400105 Miami Florida 33174 —
Investigational Site Number 8400120 Miami Florida 33176 —
Investigational Site Number 8400088 North Miami Beach Florida 33162 —
Investigational Site Number 8400106 Opa-locka Florida 33054 —
Investigational Site Number 8400063 Ormond Beach Florida 32174 —
Investigational Site Number 8400087 Palm Harbor Florida 34684-3609 —
Investigational Site Number 8400108 Spring Hill Florida 34609 —
Investigational Site Number 8400058 St. Petersburg Florida 33713 —
Investigational Site Number 8400051 Tampa Florida 33624 —
Investigational Site Number 8400123 Atlanta Georgia 30303 —
Investigational Site Number 8400076 Roswell Georgia 30076 —
Investigational Site Number 8400033 Honolulu Hawaii 96814 —
Investigational Site Number 8400085 Arlington Heights Illinois 60005 —
Investigational Site Number 8400104 Chicago Illinois 60611 —
Investigational Site Number 8400027 Chicago Illinois 60612 —
Investigational Site Number 8400124 Chicago Illinois 60612 —
Investigational Site Number 8400001 Chicago Illinois 60616 —
Investigational Site Number 8400052 Crystal Lake Illinois 60012 —
Investigational Site Number 8400028 Springfield Illinois 62711 —
Investigational Site Number 8400125 Michigan City Indiana 46360 —
Investigational Site Number 8400098 Valparaiso Indiana 46383 —
Investigational Site Number 8400003 Des Moines Iowa 50314 —
Investigational Site Number 8400081 Topeka Kansas 66606 —
Investigational Site Number 8400041 Louisville Kentucky 40213 —
Investigational Site Number 8400080 Bangor Maine 04401 —
Investigational Site Number 8400002 Flint Michigan 48504 —
Investigational Site Number 8400069 Flint Michigan 48532-3447 —
Investigational Site Number 8400016 Troy Michigan 48098 —
Investigational Site Number 8400023 Saint Cloud Minnesota 56303 —
Investigational Site Number 8400066 Kansas City Missouri 64111 —
Investigational Site Number 8400024 St Louis Missouri 63136 —
Investigational Site Number 8400130 Washington Missouri 63090 —
Investigational Site Number 8400045 Omaha Nebraska 68198-4100 —
Investigational Site Number 8400009 Las Vegas Nevada 89148 —
Investigational Site Number 8400101 Albany New York 12206 —
Investigational Site Number 8400061 Laurelton New York 11413 —
Investigational Site Number 8400046 New York New York 10029-6501 —
Investigational Site Number 8400112 Rosedale New York 11422 —
Investigational Site Number 8400062 Smithtown New York 11787 —
Investigational Site Number 8400079 Greenville North Carolina 27834-5704 —
Investigational Site Number 8400020 Morehead City North Carolina 28557 —
Investigational Site Number 8400048 Morehead City North Carolina 28557 —
Investigational Site Number 8400010 Morganton North Carolina 28655 —
Investigational Site Number 8400072 Fargo North Dakota 58103 —
Investigational Site Number 8400038 Cincinnati Ohio 45219 —
Investigational Site Number 8400007 Cincinnati Ohio 45241 —
Investigational Site Number 8400015 Columbus Ohio 43210 —
Investigational Site Number 8400113 Lorain Ohio 44053 —
Investigational Site Number 8400011 Mentor Ohio 44060 —
Investigational Site Number 8400109 Bend Oregon 97702 —
Investigational Site Number 8400047 Beaver Pennsylvania 15009 —
Investigational Site Number 8400019 Greensburg Pennsylvania 15601 —
Investigational Site Number 8400097 Indiana Pennsylvania 15701-3578 —
Investigational Site Number 8400032 Levittown Pennsylvania 19056-2404 —
Investigational Site Number 8400053 Philadelphia Pennsylvania 19107 —
Investigational Site Number 8400012 Pittsburgh Pennsylvania 15212 —
Investigational Site Number 8400064 Anderson South Carolina 29621 —
Investigational Site Number 8400030 Greer South Carolina 29651 —
Investigational Site Number 8400029 Myrtle Beach South Carolina 29572 —
Investigational Site Number 8400040 Memphis Tennessee 38163 —
Investigational Site Number 8400114 Arlington Texas 76015 —
Investigational Site Number 8400067 Corpus Christi Texas 78814 —
Investigational Site Number 8400082 Dallas Texas 75231 —
Investigational Site Number 8400022 El Paso Texas 79935 —
Investigational Site Number 8400099 Houston Texas 77043 —
Investigational Site Number 8400103 Houston Texas 77070 —
Investigational Site Number 8400086 Katy Texas 77450 —
Investigational Site Number 8400100 Mesquite Texas 75150 —
Investigational Site Number 8400094 Plano Texas 75093 —
Investigational Site Number 8400116 San Antonio Texas 78224 —
Investigational Site Number 8400091 Waco Texas 76710 —
Investigational Site Number 8400065 Bountiful Utah 84010-7717 —
Investigational Site Number 8400131 Ogden Utah 84405 —
Investigational Site Number 8400093 Bennington Vermont 05201 —
Investigational Site Number 8400060 South Burlington Vermont 05403 —
Investigational Site Number 8400133 Danville Virginia 24541-2834 —
Investigational Site Number 8400054 Fairfax Virginia 22039 —
Investigational Site Number 8400132 Falls Church Virginia 22044 —
Investigational Site Number 8400034 Manassas Virginia 20110 —
Investigational Site Number 8400050 Norfolk Virginia 23510 —
Investigational Site Number 8400044 Richmond Virginia 23235 —
Investigational Site Number 8400111 Richmond Virginia 23249 —
Investigational Site Number 8400083 Federal Way Washington 98003 —
Investigational Site Number 8400068 Spokane Washington 99207 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 635 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03315143, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 28, 2022 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03315143 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →